Published ahead of print on April 2, 2003, doi:10.1164/rccm.200302-159OC
Am. J. Respir. Crit. Care Med., Volume 168, Number 1, July 2003, 114-120
A more recent version of this article appeared on July 1, 2003
Submitted on February 4, 2003
Accepted on April 1, 2003
Endogenous nitric oxide release by vasoactive drugs monitored in exhaled air
Rickard E Malmstrom1, Daniel Tornberg2, Goran Settergren3, Jan Liska4, Monica Angdin3, Jon O Lundberg1, and Eddie Weitzberg2*
1 Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden,
2 Anaesthesiology and Intensive Care, Karolinska Hospital, Stockholm, Sweden,
3 Cardiothoracic Anaesthetics and Intensive Care, Karolinska Hospital, Stockholm, Sweden,
4 Thoracic Surgery, Karolinska Institutet, Stockholm, Sweden
* To whom correspondence should be addressed. E-mail: eddie.weitzberg{at}ks.se.
Direct measurements of endogenous NO release is of great interest but difficult to perform in vivo. We hypothesized that endogenous NO release from vasoactive substances would be detectable in exhaled air.
Exhaled NO was measured following i.v. injections of various endothelium-dependent and independent vasoactive drugs, in anaesthetized pig and man. In pigs, a dose-dependent release of exhaled NO was observed for acetylcholine, bradykinin, substance P, endothelin-1, and nitroglycerine. Each compound had an individual and highly reproducible release pattern. Bradykinin-induced NO release was enhanced by ACE inhibition. Endothelin receptor antagonism markedly reduced the response in exhaled NO to endothelin-1, while atropin abolished the NO response to acetylcholine. NO synthase inhibition abolished basal levels of exhaled NO as well as the responses in exhaled NO to all compounds except nitroglycerine. In man, acetylcholine evoked a dose-dependent increase of NO levels in exhaled air.
NO release by endogenous vasoactive agonists can be measured on-line in exhaled air of pig and man. These novel findings may be useful when characterizing NO release from compounds that interfere with NO synthesis or drugs that act as donors of NO. Moreover, the possibility of using exhaled NO as an indicator of pulmonary endothelial dysfunction merits further studies.
Key words: Acetylcholine, Endothelin, Endothelium, Nitric Oxide, Vasodilation
This article has been cited by other articles:

|
 |

|
 |
 
G. P. Fadini, M. Schiavon, M. Cantini, I. Baesso, M. Facco, M. Miorin, M. Tassinato, S. V. d. Kreutzenberg, A. Avogaro, and C. Agostini
Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease
Stem Cells,
July 1, 2006;
24(7):
1806 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate.
Proceedings of the ATS,
January 1, 2006;
3(2):
131 - 145.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Girgis, H. C. Champion, G. B. Diette, R. A. Johns, S. Permutt, and J. T. Sylvester
Decreased Exhaled Nitric Oxide in Pulmonary Arterial Hypertension: Response to Bosentan Therapy
Am. J. Respir. Crit. Care Med.,
August 1, 2005;
172(3):
352 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005
Am. J. Respir. Crit. Care Med.,
April 15, 2005;
171(8):
912 - 930.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Tornberg, M. Angdin, G. Settergen, J. Liska, J. O. Lundberg, and E. Weitzberg
Exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass--response to acetylcholine and nitroglycerin
Br. J. Anaesth.,
February 1, 2005;
94(2):
174 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Baraldi, G. Bonetto, F. Zacchello, and M. Filippone
Low Exhaled Nitric Oxide in School-Age Children with Bronchopulmonary Dysplasia and Airflow Limitation
Am. J. Respir. Crit. Care Med.,
January 1, 2005;
171(1):
68 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev,
July 1, 2004;
84(3):
731 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
239 - 253.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
265 - 276.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|